% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Reese:276826,
author = {Reese, René and Koeglsperger, Thomas and Schrader,
Christoph and Tönges, Lars and Deuschl, Günther and Kühn,
Andrea and Krack, Paul and Schnitzler, Alfons and Storch,
Alexander and Trenkwalder, Claudia and Höglinger, Günter
U},
collaboration = {Group, German Parkinson‘s Guideline},
title = {{I}nvasive therapies for {P}arkinson's disease: an adapted
excerpt from the guidelines of the {G}erman {S}ociety of
{N}eurology.},
journal = {Journal of neurology},
volume = {272},
number = {3},
issn = {0367-004X},
address = {[Darmstadt]},
publisher = {Steinkopff},
reportid = {DZNE-2025-00339},
pages = {219},
year = {2025},
abstract = {Parkinson's disease (PD) is characterized by hypokinetic
motor symptoms, tremor, and various non-motor symptoms with
frequent fluctuations of symptoms in advanced disease
stages. Invasive therapies, such as deep brain stimulation
(DBS), ablative therapies, and continuous subcutaneous or
intrajejunal delivery of dopaminergic drugs via pump
therapies are available for the management of this complex
motor symptomatology and may also impact non-motor symptoms.
The recent update of the clinical guideline on PD by the
German Neurological Society (Deutsche Gesellschaft für
Neurologie e.V.; DGN) offers clear guidance on the
indications and applications of these treatment options.The
guideline committee formulated diagnostic questions for
invasive therapies and structured them according to the
PICOS framework
(Population-Intervention-Comparisons-Outcome-Studies). A
systematic literature review was conducted. Questions were
addressed using the findings from the literature review and
consented by the guideline committee.Specific
recommendations are given regarding (i) the optimal timing
for starting invasive therapies, (ii) the application of
DBS, (iii) the use of pump therapies in advanced PD, (iv)
the indications for ablative procedures, and (iv) selecting
the most appropriate therapy according to individual patient
characteristics.This review is an adapted excerpt of the
chapters on the use of invasive therapies in PD of the novel
German guideline on PD. Clear recommendations on the use of
treatment options for advanced PD are provided.},
subtyp = {Review Article},
keywords = {Humans / Parkinson Disease: therapy / Deep Brain
Stimulation: standards / Neurology: standards / Neurology:
methods / Germany / Practice Guidelines as Topic: standards
/ Societies, Medical: standards / Ablation (Other) / Deep
brain stimulation (DBS) (Other) / Invasive therapies (Other)
/ Parkinson’s disease (Other) / Pump therapy (Other)},
cin = {Clinical Research (Munich) / AG Storch},
ddc = {610},
cid = {I:(DE-2719)1111015 / I:(DE-2719)5000014},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39985674},
pmc = {pmc:PMC11846738},
doi = {10.1007/s00415-025-12915-6},
url = {https://pub.dzne.de/record/276826},
}